The global microplate instrumentation and systems market is expected to enjoy a valuation of USD 1.0 Billion by the end of the year 2023, and further expand at a CAGR of 4.9% to reach a valuation of USD 1.6 Billion by the year 2033.
According to the recent study by Future Market Insights, microplate readers are leading the market with an expected share of about 33.7% in the year 2023, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 968.1 Million |
| Market Value 2023 | USD 1.0 Billion |
| Market Value 2033 | USD 1.6 Billion |
| CAGR 2023 to 2033 | 4.9% |
| Market Share of Top 5 Countries | 60.7% |
| Key Market Players List | A&D Company; Limited; Accuris Instruments; AESKU; Diagnostics GmbH & Co. KG; Agilent Technologies, Inc.; AHN Biotechnologie GmbH; AID GmbH; AMEDA Labordiagnostik GmbH; Andrew Alliance SA; Apricot Designs, Inc.; and Aptaca SpA |
A growing emphasis on miniaturisation and technological advancements are expected to cause the market for microplate instrumentation and systems to grow rapidly.
The market for microplate instrumentation and systems is expanding due to factors such as the pharmaceutical industry's large research and development expenditure, the increasing emphasis on miniaturisation, and the rising incidence of illnesses.
The market is also expanding as a result of the rising demand for the diagnosis and detection of numerous microorganism-related infections, the necessity to control and prevent various serious infections, as well as the rising incidence of chronic diseases like cancer and autoimmune diseases.
Growth in research and innovation activities in the domains of virology and serology could also be a driving factor in the demand for microplate instruments and systems.
Explore FMI!
Book a free demo
The market value for microplate instrumentation and systems was approximately 46.1% of the overall ~USD 2.1 Billion of the global lab automation market in 2022.
The sale of microplate instrumentation and systems expanded at a CAGR of 4.2% from 2017 to 2022.
The medical, biological, pharmaceutical, food, and cosmetics industries all use the high-quality microplate reader, which was created specifically for these fields of study.
A microplate reader is a handy tool for high-throughput measurements. By counting photons released from biochemical samples at specific wavelengths, the microplate reader has so far been able to perform a variety of biochemical quantitative experiments. The microplate reader and ELISA are used in medical tests as a high-throughput diagnostic tool for detecting biomarkers in blood or urine. The microplate reader is always used in environmental monitoring to identify and analyse the contaminants in a liquid environmental sample to assess water quality.
Overall, the microplate reader is a crucial tool for high-throughput biochemical assays in industries including medical testing, environmental control, and food analysis.
Thus, owing to the aforementioned factors, the global microplate instrumentation and systems market is expected to grow at a CAGR of 4.9% during the forecast period between 2023 and 2033.
H1-H2 Update
| Market Statistics | Details |
|---|---|
| Jan–Jun (H1), 2021 (A) | 3.57% |
| Jul–Dec (H2), 2021 (A) | 5.00% |
| Jan–Jun (H1),2022 Projected (P) | 3.40% |
| Jan–Jun (H1),2022 Outlook (O) | 3.77% |
| Jul–Dec (H2), 2022 Outlook (O) | 5.09% |
| Jul–Dec (H2), 2022 Projected (P) | 4.80% |
| Jan–Jun (H1), 2023 Projected (P) | 3.76% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 37↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | 21↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 29↑ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | 09↑ |
The market is growing due to factors including the increased prevalence of infectious and chronic diseases and the rising demand for automated biochemical and cell-based testing in the biotechnology sector.
The increased prevalence of several chronic illnesses has largely been responsible for the demand for better diagnostic tools, such as microplate instruments and systems.
In a growing number of domains, including health research, biosensing, bioactuation, chemical synthesis, and many others, microfluidics is swiftly emerging as a significant technology. This is assisting in its development from an exciting research and innovation tool to an economically viable technology. The increased emphasis on automation and improved functionality through the integration of complicated electrical control, mechanical characteristics, in situ sensing, and flow control is what is propelling this development.
Through unique technological integration and user-based adaptations, these developments are positioned to offer full-system microfluidics to the user. This factor is expected to propel the growth of the overall market over the forecast period.
For small businesses and new entrants, the market poses a significant obstacle. Innovative product development and launch require significant financial investment. In order for businesses to be competitive in the market, they must invest significantly.
Industry participants need to minimise operational costs in order to compete in the global market, which is especially difficult for small businesses and new entrants.
Recently, biotechnological methods like PCR amplification, matrix-assisted laser desorption ionisation time-of-flight spectrometry, and ELISA have been developed to speed up the pathogen detection procedure. However, these techniques call for expensive machinery and highly skilled workers. These drawbacks make it difficult to apply these bio techniques in underdeveloped nations where infectious diseases constantly endanger and strain healthcare systems.
Another drawback of this technology is its stationarity, which restricts the range of applications for a biochemical oxygen demand (BOD) sensor and has a substantial response time (approximately 1 h).
| Country | USA |
|---|---|
| Market Share (2023) | 37.4% |
| Market Share (2033) | 45.5% |
| BPS Analysis | 808 |
| Country | Germany |
|---|---|
| Market Share (2023) | 7.9% |
| Market Share (2033) | 8.8% |
| BPS Analysis | 97 |
| Country | UK |
|---|---|
| Market Share (2023) | 5.8% |
| Market Share (2033) | 9.4% |
| BPS Analysis | 356 |
| Country | China |
|---|---|
| Market Share (2023) | 4.7% |
| Market Share (2033) | 3.6% |
| BPS Analysis | -101 |
| Country | Canada |
|---|---|
| Market Share (2023) | 4.4% |
| Market Share (2033) | 4.0% |
| BPS Analysis | -33 |
The USA is set to hold a market share of about 37.4% in 2023, and is expected to continue to experience the same growth throughout the forecast period.
The government's initiatives in the area of cell-based research, the rising popularity of personalized medicine, the expansion of academic and public funding for diagnostic research and the increased attention being paid to drug discovery and development are all factors aiding in the large share that the country continues to hold.
Germany is set to hold a market share of nearly 7.9% in the global microplate instrumentation and systems market in 2022.
An increase in the number of laboratories studying biological sciences has propelled the expansion of the market within Germany. It is also expected that an increase in research labs will moderate the expansion of the global market. Growing public awareness of the importance of genetic research will open up additional prospects for the market to expand in the years to come.
China is set to hold around 4.7% of the global market share in 2023.
The Chinese government has been attempting to increase testing capacity as a result of the second wave of COVID-19 cases, which is propelling the market's expansion. Numerous pharmaceutical companies throughout the nation were actively exploring the development of the COVID-19 vaccine.
Pharmaceutical companies are placing COVID-19-related diagnostics, therapies, medical technologies, and vaccines as top priority in their research and development efforts. As a result, the market expansion in China is being positively impacted by the reasons outlined.
Microplate readers are set to hold a share of around 33.7% in the global market, in 2023.
Microplate readers are devices that analyze samples in microplates for biological, chemical, biochemical, or physical processes. Increased disease prevalence, an enhanced emphasis on drug discovery, and increased pharmaceuticals investment in research and innovation are all factors contributing to the growth of this sector.
Drug discovery segment is set to hold a share of around 37.8% in the global market in 2023. For the development of cell-based assays, microplates are used. Microplates provide an in vitro, biologically realistic method to forecast drug response.
Microplates for biochemical assays are effective at identifying, measuring, and researching the binding or function of a biological component. In drug discovery research, they harvest biologically pertinent information from cells and components, thereby increasing the value of the segment overall.
Pharmaceutical and biotechnology companies are set to hold a market share of around 46.9% in the global market in 2023.
Rising activities related to gathering significant investments in research and development by pharma and biotechnology companies for microfluidics has propelled the overall growth of the segment.
For instance, in January 2020, Casdin Capital and Viking Global Investors invested a sizable USD 250 million USD in Fluidigm. With the funds, the company will be able to expand its mass cytometry and microfluidics platforms and reach more life sciences customers worldwide.
Among the major players in the market for microplate instruments and systems are Thermo Fisher Scientific Inc., Agilent Technologies Inc., and Danaher Corporation.
Key players hold an excellent brand recognition and a wide range of products, which are their key competitive advantages in the global market. To expand their presence in the worldwide market, these businesses are concentrating on the introduction of new products and commercial ventures.
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the microplate instrumentation and systems space, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Covered | A&D Company, Limited; Accuris Instruments; AESKU, Diagnostics GmbH & Co. KG; Agilent Technologies, Inc.; AHN Biotechnologie GmbH; AID GmbH; AMEDA Labordiagnostik GmbH; Andrew Alliance SA; Apricot Designs, Inc.; Aptaca SpA |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global market size is expected to reach USD 1.6 billion by 2033.
North America is projected to emerge as a lucrative market.
The global market is expected to progress at a CAGR of 4.9% through 2033.
The rising operational costs is likely to limit the market growth.
China is likely to secure a significant CAGR of 4.7% through 2033.
Hyperammonemia Treatment Market Trends – Growth & Therapeutic Advances 2025 to 2035
Home Respiratory Therapy Market – Growth & Forecast 2025 to 2035
Veterinary Auto-Immune Therapeutics Market Growth - Trends & Forecast 2025 to 2035
Radial Compression Devices Market Growth - Trends & Forecast 2025 to 2035
Digital Telepathology Market is segmented by Application and End User from 2025 to 2035
Suture Anchor Devices Market Is Segmented by Product Type, Material Type, Tying and End User from 2025 to 2035
Microplate Instrumentation and Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
